In addition, a recent study has revealed that levels of N224 tau in AD patients were higher than that in MCI, subjective cognitive decline SCD, PD, PD dementia, multiple system atrophy, and PSP [126]. This evidence concerns the gene MAPT and Alzheimer disease.